1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis

Sudhoff H, Klenke C, Greiner J, Müller J, Brotzmann V, Ebmeyer J, Kaltschmidt B, Kaltschmidt C (2015)
PLoS ONE 10(7): e0133040.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Abstract / Bemerkung
Inflammatory diseases of the respiratory system such as rhinosinusitis, chronic obstructive pulmonary disease, or bronchial asthma are strongly associated with overproduction and hypersecretion of mucus lining the epithelial airway surface. 1,8-cineol, the active ingredient of the pharmaceutical drug Soledum, is commonly applied for treating such inflammatory airway diseases. However, its potential effects on mucus overproduction still remain unclear.In the present study, we successfully established ex vivo cultures of human nasal turbinate slices to investigate the effects of 1,8-cineol on mucus hypersecretion in experimentally induced rhinosinusitis. The presence of acetyl-α-tubulin-positive cilia confirmed the integrity of the ex vivo cultured epithelium. Mucin-filled goblet cells were also detectable in nasal slice cultures, as revealed by Alcian Blue and Periodic acid-Schiff stainings. Treatment of nasal slice cultures with lipopolysaccharides mimicking bacterial infection as observed during late rhinosinusitis led to a significantly increased number of mucin-filled goblet cells. Notably, the number of mucin-filled goblet cells was found to be significantly decreased after co-treatment with 1,8-cineol. On a molecular level, real time PCR-analysis further showed 1,8-cineol to significantly reduce the expression levels of the mucin genes MUC2 and MUC19 in close association with significantly attenuated NF-κB-activity. In conclusion, we demonstrate for the first time a 1,8-cineol-dependent reduction of mucin-filled goblet cells and MUC2-gene expression associated with an attenuated NF-κB-activity in human nasal slice cultures. Our findings suggest that these effects partially account for the clinical benefits of 1,8-cineol-based therapy during rhinosinusitis. Therefore, topical application of 1,8-cineol may offer a novel therapeutic approach to reduce bacteria-induced mucus hypersecretion.
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI


Sudhoff H, Klenke C, Greiner J, et al. 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. PLoS ONE. 2015;10(7): e0133040.
Sudhoff, H., Klenke, C., Greiner, J., Müller, J., Brotzmann, V., Ebmeyer, J., Kaltschmidt, B., et al. (2015). 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. PLoS ONE, 10(7), e0133040. https://doi.org/10.1371/journal.pone.0133040
Sudhoff, H., Klenke, C., Greiner, J., Müller, J., Brotzmann, V., Ebmeyer, J., Kaltschmidt, B., and Kaltschmidt, C. (2015). 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. PLoS ONE 10:e0133040.
Sudhoff, H., et al., 2015. 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. PLoS ONE, 10(7): e0133040.
H. Sudhoff, et al., “1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis”, PLoS ONE, vol. 10, 2015, : e0133040.
Sudhoff, H., Klenke, C., Greiner, J., Müller, J., Brotzmann, V., Ebmeyer, J., Kaltschmidt, B., Kaltschmidt, C.: 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. PLoS ONE. 10, : e0133040 (2015).
Sudhoff, Holger, Klenke, Christin, Greiner, Johannes, Müller, Janine, Brotzmann, Viktoria, Ebmeyer, Jörg, Kaltschmidt, Barbara, and Kaltschmidt, Christian. “1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis”. PLoS ONE 10.7 (2015): e0133040.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Access Level
OA Open Access
Zuletzt Hochgeladen
MD5 Prüfsumme

2 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Mucus models to evaluate the diffusion of drugs and particles.
Lock JY, Carlson TL, Carrier RL., Adv Drug Deliv Rev 124(), 2018
PMID: 29117512
Stem cells in middle ear cholesteatoma contribute to its pathogenesis.
Nagel J, Wöllner S, Schürmann M, Brotzmann V, Müller J, Greiner JF, Goon P, Kaltschmidt B, Kaltschmidt C, Sudhoff H., Sci Rep 8(1), 2018
PMID: 29670222

36 References

Daten bereitgestellt von Europe PubMed Central.

Mucus clearance as a primary innate defense mechanism for mammalian airways.
Knowles MR, Boucher RC., J. Clin. Invest. 109(5), 2002
PMID: 11877463
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.
Caramori G, Di Gregorio C, Carlstedt I, Casolari P, Guzzinati I, Adcock IM, Barnes PJ, Ciaccia A, Cavallesco G, Chung KF, Papi A., Histopathology 45(5), 2004
PMID: 15500651
Respiratory tract mucin genes and mucin glycoproteins in health and disease.
Rose MC, Voynow JA., Physiol. Rev. 86(1), 2006
PMID: 16371599
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.
Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ., Nat. Med. 8(8), 2002
PMID: 12091879
Mucins, mucus, and sputum.
Voynow JA, Rubin BK., Chest 135(2), 2009
PMID: 19201713
Structure and function of the polymeric mucins in airways mucus.
Thornton DJ, Rousseau K, McGuckin MA., Annu. Rev. Physiol. 70(), 2008
PMID: 17850213
Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis.
Kim DH, Chu HS, Lee JY, Hwang SJ, Lee SH, Lee HM., Arch. Otolaryngol. Head Neck Surg. 130(6), 2004
PMID: 15210557
Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.
Thornton DJ, Sheehan JK, Lindgren H, Carlstedt I., Biochem. J. 276 ( Pt 3)(), 1991
PMID: 2064605
Mucins in airway secretions from healthy and chronic bronchitic subjects.
Davies JR, Hovenberg HW, Linden CJ, Howard R, Richardson PS, Sheehan JK, Carlstedt I., Biochem. J. 313 ( Pt 2)(), 1996
PMID: 8573075
Mucus and MUC in asthma.
Morcillo EJ, Cortijo J., Curr Opin Pulm Med 12(1), 2006
PMID: 16357571
Regulation of airway mucin gene expression.
Thai P, Loukoianov A, Wachi S, Wu R., Annu. Rev. Physiol. 70(), 2008
PMID: 17961085
Étude chimique de l’eucalyptol
Effects of volatile constituents of a rosemary extract on allergic airway inflammation related to house dust mite allergen in mice.
Inoue K, Takano H, Shiga A, Fujita Y, Makino H, Yanagisawa R, Ichinose T, Kato Y, Yamada T, Yoshikawa T., Int. J. Mol. Med. 16(2), 2005
PMID: 16012768
Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial.
Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H., Respir Med 97(3), 2003
PMID: 12645832
A mouse model of acute bacterial rhinosinusitis.
Bomer K, Brichta A, Baroody F, Boonlayangoor S, Li X, Naclerio RM., Arch. Otolaryngol. Head Neck Surg. 124(11), 1998
PMID: 9821924
Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria.
Dohrman A, Miyata S, Gallup M, Li JD, Chapelin C, Coste A, Escudier E, Nadel J, Basbaum C., Biochim. Biophys. Acta 1406(3), 1998
PMID: 9630659
1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity.
Greiner JF, Muller J, Zeuner MT, Hauser S, Seidel T, Klenke C, Grunwald LM, Schomann T, Widera D, Sudhoff H, Kaltschmidt B, Kaltschmidt C., Biochim. Biophys. Acta 1833(12), 2013
PMID: 23872422
Anatomy, physiology and function of the nasal cavities in health and disease.
Dahl R, Mygind N., Adv. Drug Deliv. Rev. 29(1-2), 1998
PMID: 10837577
Isolation of novel multipotent neural crest-derived stem cells from adult human inferior turbinate.
Hauser S, Widera D, Qunneis F, Muller J, Zander C, Greiner J, Strauss C, Luningschror P, Heimann P, Schwarze H, Ebmeyer J, Sudhoff H, Arauzo-Bravo MJ, Greber B, Zaehres H, Scholer H, Kaltschmidt C, Kaltschmidt B., Stem Cells Dev. 21(5), 2012
PMID: 22128806
Alcian blue 8GS: a new stain for mucin.
STEEDMAN HF., Q J Microsc Sci 91(4), 1950
PMID: 24540170
Effects of a tumor necrosis factor-α antagonist on experimentally induced rhinosinusitis.
Kim DH, Jeon EJ, Park SN, Park KH, Park YS, Yeo SW., J. Biomed. Biotechnol. 2011(), 2011
PMID: 21772791
Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.
Jono H, Shuto T, Xu H, Kai H, Lim DJ, Gum JR Jr, Kim YS, Yamaoka S, Feng XH, Li JD., J. Biol. Chem. 277(47), 2002
PMID: 12237307
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease.
Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, Nadel JA, Prince A, Basbaum CB., Proc. Natl. Acad. Sci. U.S.A. 94(3), 1997
PMID: 9023366
Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells.
Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C., Proc. Natl. Acad. Sci. U.S.A. 95(10), 1998
PMID: 9576950
1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice.
Zhao C, Sun J, Fang C, Tang F., Inflammation 37(2), 2014
PMID: 24197825
Inhaled 1,8-cineole reduces inflammatory parameters in airways of ovalbumin-challenged Guinea pigs.
Bastos VP, Gomes AS, Lima FJ, Brito TS, Soares PM, Pinho JP, Silva CS, Santos AA, Souza MH, Magalhaes PJ., Basic Clin. Pharmacol. Toxicol. 108(1), 2010
PMID: 20722639
Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells.
Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP, Shelhamer JH., Am. J. Respir. Cell Mol. Biol. 12(2), 1995
PMID: 7865217
Mucin gene 19 (MUC19) expression and response to inflammatory cytokines in middle ear epithelium.
Kerschner JE, Khampang P, Erbe CB, Kolker A, Cioffi JA., Glycoconj. J. 26(9), 2009
PMID: 19533339


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 26207629
PubMed | Europe PMC

Suchen in

Google Scholar